T. Rowe Price Associates’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.49M Buy
47,305
+4,753
+11% +$150K ﹤0.01% 1785
2025
Q1
$1.39M Buy
42,552
+2,124
+5% +$69.6K ﹤0.01% 1779
2024
Q4
$1.46M Sell
40,428
-6,969
-15% -$252K ﹤0.01% 1783
2024
Q3
$1.48M Sell
47,397
-126
-0.3% -$3.93K ﹤0.01% 1783
2024
Q2
$1.27M Sell
47,523
-395,234
-89% -$10.6M ﹤0.01% 1783
2024
Q1
$15.1M Sell
442,757
-2,559
-0.6% -$87.3K ﹤0.01% 1039
2023
Q4
$12.9M Sell
445,316
-32,064
-7% -$928K ﹤0.01% 1043
2023
Q3
$13.2M Sell
477,380
-35,624
-7% -$982K ﹤0.01% 1012
2023
Q2
$15.4M Buy
513,004
+3,032
+0.6% +$91.1K ﹤0.01% 1000
2023
Q1
$18.5M Buy
509,972
+619
+0.1% +$22.4K ﹤0.01% 937
2022
Q4
$18.2M Buy
509,353
+1,490
+0.3% +$53.1K ﹤0.01% 936
2022
Q3
$17.2M Sell
507,863
-885
-0.2% -$30K ﹤0.01% 946
2022
Q2
$14.7M Sell
508,748
-7,479
-1% -$216K ﹤0.01% 1242
2022
Q1
$16.7M Sell
516,227
-694
-0.1% -$22.4K ﹤0.01% 1275
2021
Q4
$15.1M Sell
516,921
-5,309
-1% -$155K ﹤0.01% 1339
2021
Q3
$13.9M Sell
522,230
-85,163
-14% -$2.27M ﹤0.01% 1378
2021
Q2
$18.7M Sell
607,393
-990
-0.2% -$30.5K ﹤0.01% 1315
2021
Q1
$15.9M Sell
608,383
-26,594
-4% -$696K ﹤0.01% 1323
2020
Q4
$16M Sell
634,977
-59,138
-9% -$1.49M ﹤0.01% 1270
2020
Q3
$14.5M Sell
694,115
-837
-0.1% -$17.4K ﹤0.01% 1217
2020
Q2
$16.5M Buy
694,952
+7,633
+1% +$181K ﹤0.01% 1187
2020
Q1
$12.4M Sell
687,319
-91,977
-12% -$1.65M ﹤0.01% 1192
2019
Q4
$18.5M Buy
779,296
+19,671
+3% +$467K ﹤0.01% 1209
2019
Q3
$20.9M Sell
759,625
-12,160
-2% -$334K ﹤0.01% 1136
2019
Q2
$25.5M Buy
771,785
+1,677
+0.2% +$55.5K ﹤0.01% 1108
2019
Q1
$27M Buy
770,108
+2,520
+0.3% +$88.3K ﹤0.01% 1081
2018
Q4
$25.5M Sell
767,588
-6,733
-0.9% -$224K ﹤0.01% 1070
2018
Q3
$39M Buy
774,321
+13,066
+2% +$658K 0.01% 1004
2018
Q2
$45.6M Buy
761,255
+57,468
+8% +$3.44M 0.01% 937
2018
Q1
$32.2M Sell
703,787
-5,431
-0.8% -$249K 0.01% 1023
2017
Q4
$28.3M Buy
709,218
+36,537
+5% +$1.46M ﹤0.01% 1057
2017
Q3
$26.9M Buy
672,681
+50,352
+8% +$2.01M ﹤0.01% 1073
2017
Q2
$26.8M Buy
622,329
+37,468
+6% +$1.61M ﹤0.01% 1067
2017
Q1
$18.3M Buy
584,861
+271,216
+86% +$8.49M ﹤0.01% 1192
2016
Q4
$7.92M Buy
313,645
+290,960
+1,283% +$7.35M ﹤0.01% 1351
2016
Q3
$561K Sell
22,685
-26,175
-54% -$647K ﹤0.01% 1964
2016
Q2
$995K Buy
48,860
+4,850
+11% +$98.8K ﹤0.01% 1710
2016
Q1
$671K Sell
44,010
-434,420
-91% -$6.62M ﹤0.01% 1853
2015
Q4
$6.43M Sell
478,430
-500,235
-51% -$6.72M ﹤0.01% 1378
2015
Q3
$13.7M Sell
978,665
-95,584
-9% -$1.34M ﹤0.01% 1221
2015
Q2
$18.2M Buy
1,074,249
+12,799
+1% +$217K ﹤0.01% 1164
2015
Q1
$12.8M Sell
1,061,450
-360,382
-25% -$4.36M ﹤0.01% 1263
2014
Q4
$11.8M Sell
1,421,832
-935,818
-40% -$7.77M ﹤0.01% 1274
2014
Q3
$20.5M Sell
2,357,650
-1,071,240
-31% -$9.31M ﹤0.01% 1106
2014
Q2
$37.5M Sell
3,428,890
-757,661
-18% -$8.3M 0.01% 949
2014
Q1
$37.4M Sell
4,186,551
-176,249
-4% -$1.58M 0.01% 942
2013
Q4
$32.9M Sell
4,362,800
-141,800
-3% -$1.07M 0.01% 958
2013
Q3
$33M Sell
4,504,600
-235,100
-5% -$1.72M 0.01% 950
2013
Q2
$30.5M Buy
+4,739,700
New +$30.5M 0.01% 950